How have RVMDW shares performed in 2024?

Revolution Medicines' stock was trading at $0.33 on January 1st, 2024. Since then, RVMDW stock has decreased by 49.7% and is now trading at $0.1661. View the best growth stocks for 2024 here .

Are investors shorting Revolution Medicines?

Revolution Medicines saw a drop in short interest in the month of May. As of May 15th, there was short interest totaling 6,800 shares, a drop of 29.9% from the April 30th total of 9,700 shares. Based on an average daily volume of 1,800 shares, the short-interest ratio is currently 3.8 days. View Revolution Medicines' Short Interest .

How do I buy shares of Revolution Medicines?

Shares of RVMDW stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here .

NASDAQ:RVMDW

Revolution Medicines (RVMDW) Stock Price, News & Analysis

→ Do This Before July 30 2024 To Claim Trump’s Gift (From Wealthpin Pro) (Ad)

Free RVMDW Stock Alerts

$0.17

0.00 (0.00%)

(As of 05/31/2024 ET)

Compare

Today's Range: $0.17
▼
$0.17
50-Day Range: $0.15
▼
$0.37
52-Week Range: $0.03
▼
$1.05

Volume: 116 shs
Average Volume: 7,423 shs
Market Capitalization: N/A

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Stock Analysis Chart Competitors Financials SEC Filings Short Interest Trends

Get Revolution Medicines alerts:

Ad Porter & Company

This military-backed stock “owns” AI market

The AI boom is just getting started. And the real wealth has still to be made…

You must read this new presentation from Porter Stansberry.

About Revolution Medicines

Revolution Medicines, Inc., a clinical-stage precision oncology company, develops novel targeted therapies for RAS-addicted cancers. The company's research and development pipeline comprises RAS(ON) inhibitors designed to be used as monotherapy in combination with other RAS(ON) inhibitors and/or in combination with RAS companion inhibitors or other therapeutic agents, and RAS companion inhibitors for combination treatment strategies. Its RAS(ON) inhibitors include RMC-6236 (multi), RMC-6291 (G12C), and RMC-9805 (G12D), which are in phase 1 clinical trial; and development candidates comprise RMC-5127 (G12V), RMC-0708 (Q61H), and RMC-8839 (G13C), as well as programs focused on G12R and other targets. The company's RAS companion inhibitors include RMC-4630 that is in phase 2 clinical trial; and RMC-5552, which is in phase 1 clinical trial. Revolution Medicines, Inc. was incorporated in 2014 and is headquartered in Redwood City, California.

RVMDW Stock Price History

30 days | 90 days | 365 days | Advanced Chart

RVMDW Stock News Headlines

No headlines for this company have been tracked by MarketBeat.com

Receive RVMDW Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Revolution Medicines and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Sector: Medical
Industry: Biotechnology
Sub-Industry: N/A
Current Symbol: NASDAQ:RVMDW
CUSIP: N/A
CIK: 1628171
Web: www.revmed.com
Phone: 650-481-6801
Fax: N/A
Employees: 378
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: N/A
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: N/A
Quick Ratio: N/A

Sales & Book Value

Annual Sales: $4.57 million
Price / Sales: N/A
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: N/A
Price / Book: N/A

Miscellaneous

Outstanding Shares: N/A
Free Float: N/A
Market Cap: N/A
Optionable: N/A
Beta: N/A

7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google

Growth stocks offer a lot of bang for your buck, and we've got the next upcoming superstars to strongly consider for your portfolio.

Get This Free Report

Key Executives

Dr. Mark A. Goldsmith Ph.D. (Age 62)
CEO, President & Chairman
Comp: $1.05M
Mr. Jack Anders (Age 47)
Chief Financial Officer
Comp: $544.8k
Ms. Margaret A. Horn J.D. (Age 61)
Chief Operating Officer
Comp: $775.6k
Dr. Stephen M. Kelsey FRC Path. (Age 63)
FRCP, M.D., President of Research & Development
Comp: $779k
Ms. Xiaolin Wang (Age 53)
Executive Vice President of Clinical Development
Comp: $604.1k
Dr. Martin D. Burke M.D.
Ph.D., Co-Founder & Chairman of Scientific Advisory Board
Dr. Michael A. Fischbach Ph.D. (Age 43)
Academic Co-Founder & Member of Scientific Advisory Board
Dr. Kevan M. Shokat Ph.D.
Academic Co-Founder & Member of Scientific Advisory Board
Mr. Walter Reiher Ph.D.
Chief Information Officer
Ms. Jan Smith Ph.D.
Chief Scientific Officer

Key Competitors

View All Competitors

RVMDW Stock Analysis - Frequently Asked Questions

How have RVMDW shares performed in 2024?: Revolution Medicines' stock was trading at $0.33 on January 1st, 2024. Since then, RVMDW stock has decreased by 49.7% and is now trading at $0.1661.
View the best growth stocks for 2024 here.
Are investors shorting Revolution Medicines?: Revolution Medicines saw a drop in short interest in the month of May. As of May 15th, there was short interest totaling 6,800 shares, a drop of 29.9% from the April 30th total of 9,700 shares. Based on an average daily volume of 1,800 shares, the short-interest ratio is currently 3.8 days.
View Revolution Medicines' Short Interest.
How do I buy shares of Revolution Medicines?: Shares of RVMDW stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:RVMDW) was last updated on 6/2/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial